Keyphrases
Antiarrhythmic Therapy
16%
Arrhythmia
73%
Cardiac Sodium Channel
37%
Channel Dynamics
14%
Channel Interaction
18%
Channel Model
14%
Class I Antiarrhythmics
25%
Clinical Datasets
12%
Computational Approach
25%
Computational Model
15%
Computational Modeling
18%
Computational Tools
12%
Drug Interactions
13%
Drug Repositioning
12%
Drug Therapy
25%
Drug Toxicity
15%
Electrical Activity
25%
Electrophysiology
31%
Flecainide
24%
Heart Failure
14%
Heart Failure Management
12%
Heart muscle
26%
Hypertrophic Cardiomyopathy
25%
In Silico
16%
Induced Pluripotent Stem Cells (iPSCs)
25%
Inherited Arrhythmia Syndrome
17%
Interactions with Drugs
12%
Ion Channel Kinetics
40%
Ion Channels
41%
Kinetic Model
37%
Late INa
13%
Late Na+ Current
12%
Left Ventricular Aneurysm
12%
Lidocaine
18%
Long QT Syndrome Type 3
14%
Markov Model
18%
Mexiletine
25%
Myocytes
18%
Na +
20%
Na+ Channel
16%
Na+ Current
15%
Old Drugs
12%
Pathophysiology
25%
Pharmacological Management
19%
Ranolazine
16%
Right Ventricular
15%
Treatment Strategy
17%
Tricuspid Annular Plane Systolic Excursion (TAPSE)
12%
Ventricular Arrhythmia
42%
Voltage Sensor Domain
13%
Pharmacology, Toxicology and Pharmaceutical Science
Antiarrhythmic Agent
12%
Antiarrhythmic Drug
39%
Antimalarial Agent
12%
Arrhythmogenesis
12%
Catecholaminergic Polymorphic Ventricular Tachycardia
12%
Clinical Trial
12%
Combination Therapy
6%
Congestive Heart Failure
25%
Diseases
13%
Drug Repositioning
12%
Drug Toxicity
15%
Flecainide
17%
Heart Arrhythmia
100%
Hydroxychloroquine
12%
Hypertrophic Cardiomyopathy
12%
Ion Channel
28%
Lidocaine
11%
Long QT Syndrome
17%
Mexiletine
22%
Pathophysiology
16%
Pharmacotherapy
16%
Ranolazine
16%
Sodium Channel
31%
Sodium Ion
16%
Syndrome
24%
